Grove Bank & Trust’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $792K | Buy |
6,271
+500
| +9% | +$65.9K | 0.08% | 134 |
|
|
2026
Q1 | $804K | Buy |
5,771
+8
| +0.1% | +$1.12K | 0.09% | 129 |
|
|
2025
Q4 | $707K | Buy |
5,763
+50
| +0.9% | +$6.08K | 0.08% | 145 |
|
|
2025
Q3 | $634K | Sell |
5,713
-40
| -0.7% | -$4.55K | 0.07% | 150 |
|
|
2025
Q2 | $638K | Buy |
5,753
+113
| +2% | +$12K | 0.08% | 146 |
|
|
2025
Q1 | $632K | Buy |
5,640
+3,572
| +173% | +$369K | 0.08% | 146 |
|
|
2024
Q4 | $191K | Buy |
2,068
+41
| +2% | +$3.69K | 0.03% | 223 |
|
|
2024
Q3 | $170K | Sell |
2,027
-158
| -7% | -$12.1K | 0.03% | 237 |
|
|
2024
Q2 | $150K | Sell |
2,185
-1,005
| -32% | -$67.1K | 0.02% | 251 |
|
|
2024
Q1 | $234K | Sell |
3,190
-4,974
| -61% | -$382K | 0.04% | 208 |
|
|
2023
Q4 | $661K | Sell |
8,164
-674
| -8% | -$52.4K | 0.12% | 125 |
|
|
2023
Q3 | $662K | Buy |
8,838
+227
| +3% | +$17.5K | 0.14% | 121 |
|
|
2023
Q2 | $664K | Sell |
8,611
-2,415
| -22% | -$193K | 0.13% | 122 |
|
|
2023
Q1 | $915K | Sell |
11,026
-7,449
| -40% | -$617K | 0.19% | 96 |
|
|
2022
Q4 | $1.59M | Sell |
18,475
-612
| -3% | -$48.5K | 0.35% | 61 |
|
|
2022
Q3 | $1.18M | Buy |
19,087
+3,053
| +19% | +$193K | 0.29% | 70 |
|
|
2022
Q2 | $991K | Buy |
16,034
+3,375
| +27% | +$209K | 0.24% | 88 |
|
|
2022
Q1 | $753K | Buy |
12,659
+344
| +3% | +$22K | 0.15% | 120 |
|
|
2021
Q4 | $894K | Sell |
12,315
-102
| -0.8% | -$7.03K | 0.17% | 110 |
|
|
2021
Q3 | $867K | Buy |
12,417
+328
| +3% | +$23K | 0.18% | 104 |
|
|
2021
Q2 | $832K | Buy |
12,089
+1,163
| +11% | +$77.7K | 0.18% | 112 |
|
|
2021
Q1 | $706K | Buy |
10,926
+1,781
| +19% | +$115K | 0.17% | 116 |
|
|
2020
Q4 | $533K | Buy |
9,145
+1,003
| +12% | +$60.5K | 0.14% | 124 |
|
|
2020
Q3 | $514K | Buy |
8,142
+3,347
| +70% | +$232K | 0.16% | 117 |
|
|
2020
Q2 | $369K | Sell |
4,795
-1,062
| -18% | -$81.4K | 0.12% | 134 |
|
|
2020
Q1 | $438K | Buy |
5,857
+2,285
| +64% | +$158K | 0.17% | 119 |
|
|
2019
Q4 | $232K | Buy |
+3,572
| New | +$233K | 0.07% | 172 |
|
|
2018
Q1 | – | Sell |
-2,591
| Closed | -$186K | – | 282 |
|
|
2017
Q4 | $186K | Buy |
2,591
+55
| +2% | +$4.18K | 0.08% | 163 |
|
|
2017
Q3 | $205K | Buy |
2,536
+1,696
| +202% | +$130K | 0.1% | 155 |
|
|
2017
Q2 | $59K | Buy |
840
+530
| +171% | +$35.3K | 0.04% | 236 |
|
|
2017
Q1 | $21K | Sell |
310
-800
| -72% | -$56.3K | 0.02% | 294 |
|
|
2016
Q4 | $79K | Buy |
1,110
+310
| +39% | +$23K | 0.06% | 172 |
|
|
2016
Q3 | $63K | Sell |
800
-1,028
| -56% | -$83.5K | 0.05% | 141 |
|
|
2016
Q2 | $152K | Hold |
1,828
| – | – | 0.14% | 103 |
|
|
2016
Q1 | $168K | Hold |
1,828
| – | – | 0.15% | 99 |
|
|
2015
Q4 | $185K | Buy |
+1,828
| New | +$190K | 0.17% | 97 |
|
Other funds holding GILD
LMFP
CIM
CGH
CNB
AP
COPPSERS
Grove Bank & Trust's GILD Position: Q2 2026 in Review
Grove Bank & Trust increased its Gilead Sciences (GILD) stake by 8.7% in Q2 2026, buying an estimated $65.9K and bringing the position to 6,271 shares worth $792K. The position accounts for 0.08% of the portfolio, ranked #134.
Grove Bank & Trust first reported a position in GILD in Q4 2015 and has held it in 36 quarters since. The position peaked at $1.59M in Q4 2022. 361 funds tracked by Wall St. Rank hold GILD as of Q2 2026.
- Grove Bank & Trust held 6,271 shares of Gilead Sciences worth $792K as of Q2 2026.
- Grove Bank & Trust bought 500 Gilead Sciences shares in Q2 2026, an estimated $65.9K.
- Gilead Sciences made up 0.08% of Grove Bank & Trust's portfolio in Q2 2026, its #134 holding.
- Grove Bank & Trust first reported a position in Gilead Sciences in Q4 2015 and has held it in 36 quarters since.
- Grove Bank & Trust's Gilead Sciences position peaked at $1.59M in Q4 2022.
- 361 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.
Based on Grove Bank & Trust's 13F filing for Q2 2026, filed 7 Jul 2026.